---
title: "Medicus Pharma To Highlight SkinJect Phase 2 Data And Teverelix Clinical Advances At BIO 2026"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290432778.md"
description: "Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutic assets, today announced that it will participate in the 2026 Bio International Conference, being held on June 22-25, 2026, in San Diego, California."
datetime: "2026-06-22T12:00:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290432778.md)
  - [en](https://longbridge.com/en/news/290432778.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290432778.md)
generator: "portal-rs"
---

# Medicus Pharma To Highlight SkinJect Phase 2 Data And Teverelix Clinical Advances At BIO 2026

Medicus Pharma Ltd. (NASDAQ: **MDCX**) (“Medicus” or the “Company”), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutic assets, today announced that it will participate in the 2026 Bio International Conference, being held on June 22-25, 2026, in San Diego, California.

### Related Stocks

- [MDCX.US](https://longbridge.com/en/quote/MDCX.US.md)
- [MDCXW.US](https://longbridge.com/en/quote/MDCXW.US.md)

## Related News & Research

- [Medicus Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update | MDCX Stock News](https://longbridge.com/en/news/295715209.md)
- [McKenzie Scott PC Announces Three San Diego Civil Rights Case Outcomes](https://longbridge.com/en/news/296538482.md)
- [MEDI: Record sales and profit in Q2/H1 2026, with strong growth in own products and key regions](https://longbridge.com/en/news/296576263.md)
- [Baseball-MLB owners unanimously approve sale of San Diego Padres](https://longbridge.com/en/news/296137237.md)
- [MEDI: Record sales, high margins, and upgraded growth outlook driven by strong global demand](https://longbridge.com/en/news/296593258.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**